Lv5
1410 积分 2025-03-04 加入
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia
10天前
已完结
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial
10天前
已完结
Fixed-dose combination of obicetrapib and ezetimibe for LDL cholesterol reduction (TANDEM): a phase 3, randomised, double-blind, placebo-controlled trial
10天前
已完结
† Safety and efficacy of obicetrapib in patients with heterozygous familial hypercholesterolemia
10天前
已关闭
Update on Antiseizure Medications 2025
15天前
已完结
Pitolisant versus placebo or modafinil in patients with narcolepsy: a double-blind, randomised trial
21天前
已完结
First-in-human phase I studies of YJ001 spray applied to local skin in healthy subjects and patients with diabetic neuropathic pain
27天前
已完结
TERN-501, a potent and selective agonist of thyroid hormone receptor beta, strongly reduces histological features and biomarkers of non-alcoholic steatohepatitis associated pathology in rodent models
1个月前
已完结
A Review of the progress and challenges of developing dendritic-based vaccines against hepatitis B virus (HBV)
1个月前
已完结
Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis
1个月前
已完结
皖公网安备34019202002308
